Saia Broadens Footprint in Western U.S. with Key Terminal Openings The new facilities will drive enhanced service and regional growth in Bismarck, Fargo, and Sidney. JOHNS CREEK, Ga., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Saia Inc. (NASDAQ: SAIA) is excited to announce that Saia LTL Freight, a leading less-than-truckload (LTL) carrier, is opening three new terminals this month, further expanding its Western U.S. footprint as the company celebrates its 100th anniversary. The new terminals in Bismarck and Fargo, North Dakota, and Sidney, Montana, represent key milestones in Saia’s strategic ...
A director at Paycom Software Inc sold 3,900 shares at 170.274USD and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
NASA Awards Intuitive Machines Near Space Network Contract with a Maximum Potential Value of $4.82 Billion HOUSTON, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”), a leading space exploration, infrastructure, and services company, today announced NASA has awarded the Company a Near Space Network (“NSN”) contract for communication and navigation services for missions in the near space region, which extends from Earth’s surface to beyond the Moon. This Subcategory 2.2 Geostationary Orbit to Cislunar Relay Services is a n...
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis WAYNE, Pa., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that the first patient has been dosed in Aclaris' Phase 2a clinical trial of ATI-2138, an investigational oral covalent inhibitor of interleukin-2-inducible T cell kin...
A director at Transocean Ltd bought 1,500,000 shares at 4.130USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
With uncertainty among investors due to flattish near-term deepwater demand and increasing availability of tier-2 deepwater rigs, we highlight that supply-side discipline has been a key driver this upcycle. As the industry is even more consolidated, we expect the high-end of the deepwater market to remain strong while lower-end units are likely to face greater day-rate volatility. We still see value chain bottlenecks (FPSO, subsea) unfolding, effectively putting a cap on drilling demand, as expl...
Transocean Ltd. Announces $232 Million Ultra-Deepwater Drillship Contract STEINHAUSEN, Switzerland, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) (“Transocean”) today announced a 365-day contract for the Deepwater Atlas with bp in the U.S. Gulf of Mexico. The contract also provides for a 365-day option. The program is expected to commence in the second quarter of 2028 and contribute approximately $232 million in backlog, excluding a mobilization fee. There are no additional services provided under the contract. About Transocean Transocean is a leading international prov...
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York. A webcast of the fireside chat may be accessed through the “Events” page of the “In...
ADES announced it has acquired two working premium jackups from Vantage Drilling for USD190m (Soehanah USD85m, Topaz Driller USD105m). Both are on long-term contracts in Southeast Asia, marking a strategic move for ADES in further increasing its presence in the region. Compared to consensus, we find the transaction metrics accretive on asset values and earnings multiples. For international drillers in our coverage, Borr Drilling is trading at USD138m per rig (has a more modern fleet of premium j...
Intuitive Machines Announces Key Leadership Appointments HOUSTON, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”), a leading space exploration, infrastructure, and services company, announced that effective September 16, 2024, Pete McGrath will transition from his current role of Senior Vice President, Chief Operating Officer into the role of Senior Vice President and Chief Financial Officer. Steven Vontur will transition from serving as the Company’s Interim Chief Financial Officer to Chief Accounting Officer and Contro...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.